Investing.comQwen · 实盘不做把握 0/10不做原因:无增量信息
北京时间·🕒 发布 04:36:36·⟳ 抓取 04:39:05 +2m29s·⚡ 决策 08-27 10:24:19 +5h45m·61.6 天前
Veeva Systems Q2 FY2027财报全面超预期并上调全年指引
本条Investing.com文章与此前已处理的两条记录（08-27 01:58 UTC「Veeva Announces Fiscal 2027 Second Quarter Results」及08-26 20:08 UTC「VEEVA SYSTEMS $VEEV Q2'27 EARNINGS HIGHLIGHTS」）为同一具体催化：同一份Q2 FY2027财报、相同数字（收入$928M、EPS $2.35、全年指引$3.682-3.687B）、相同定性要点（Vault CRM最佳季度）。本条无任何新增金额、指引修正、官方确认/否认或其他足以改变结论的事实。
📄 原文Investing.com↗ 原文
Veeva Systems soars 9% on strong Q2 beat, FY guidance amid momentum in Vault CRM
Nvidia quarterly revenue more than doubles, guidance beats; stock down after hours PLEASANTON, Calif. - Veeva Systems I…
不做 Veeva Systems（VEEV.US）
重复消息：同一Q2 FY2027财报催化已被08-27 01:58 UTC（news_center）和08-26 20:08 UTC（twitter）两条记录处理并判不做。本条Investing.com文章无新增金额、指引修正或官方确认/否认，不构成独立催化。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
Veeva Q2 FY2027财报超预期（收入+2.5%、EPS+5.9%超共识、全年指引上调）已于数小时前被两条独立来源处理并判定不做：盘后+9%已基本完成定价，此前20日+17.7%存在抢跑，剩余edge不足。本条Investing.com AI生成摘要为同一事件的延迟转载，无新增信息，判为重复。
🔎 新鲜度:最早出现 2026-08-26 · 扩散 high · price-in 风险 high ↗
先例如何影响了这次决策
对本次决策的影响:重复消息，未进入先例研究
工具调用 · 历史记录,结果未知(2 种)
- fetch_decision_experience · 结果未知
- search_processed_events · 结果未知
原文全文
展开原文 · 2,063 字
Nvidia quarterly revenue more than doubles, guidance beats; stock down after hours
PLEASANTON, Calif. - Veeva Systems Inc. (NYSE:VEEV) reported second quarter results that exceeded analyst expectations across all metrics, driving shares up 9% in after hours trading on Wednesday as the company provided an upbeat full-year outlook.
The life sciences software provider posted adjusted earnings per share of $2.35, beating the analyst consensus of $2.22 by $0.13. Revenue reached $928.0 million, surpassing the estimate of $905.41 million and representing an 18% increase YoY from $789.1 million in the prior-year period. Subscription revenues grew 16% YoY to $766.8 million.
For the third quarter, Veeva issued guidance of $932-935 million in revenue, with the midpoint of $933.5 million exceeding the analyst consensus of $917.9 million. The company expects adjusted EPS of $2.33-$2.34, above the $2.28 consensus. For fiscal 2027, Veeva raised its full-year revenue outlook to $3.682-3.687 billion, compared to the previous consensus of $3.646 billion, with adjusted EPS of approximately $9.21.
"AI is opening up the next big chapter for Veeva and life sciences," said CEO Peter Gassner. "Vault CRM had its best quarter ever and Veeva Falcon accelerated rapidly."
CFO Brian Van Wagener noted, "Second quarter results exceeded guidance on all metrics and our view for the full year improved across the board."
The company reported strong momentum in its Vault CRM platform, which now has more than 180 customers live, including five top 20 biopharmas. Veeva also highlighted progress with its Veeva Falcon agentic labor platform for clinical, regulatory, and safety functions, which has five early adopters and is on track for initial deployments this year.
Adjusted operating income for the quarter was $415.9 million, up 18% YoY from $352.6 million, while adjusted net income increased 16% to $387.4 million from $333.4 million in the year-ago period.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
PLEASANTON, Calif. - Veeva Systems Inc. (NYSE:VEEV) reported second quarter results that exceeded analyst expectations across all metrics, driving shares up 9% in after hours trading on Wednesday as the company provided an upbeat full-year outlook.
The life sciences software provider posted adjusted earnings per share of $2.35, beating the analyst consensus of $2.22 by $0.13. Revenue reached $928.0 million, surpassing the estimate of $905.41 million and representing an 18% increase YoY from $789.1 million in the prior-year period. Subscription revenues grew 16% YoY to $766.8 million.
For the third quarter, Veeva issued guidance of $932-935 million in revenue, with the midpoint of $933.5 million exceeding the analyst consensus of $917.9 million. The company expects adjusted EPS of $2.33-$2.34, above the $2.28 consensus. For fiscal 2027, Veeva raised its full-year revenue outlook to $3.682-3.687 billion, compared to the previous consensus of $3.646 billion, with adjusted EPS of approximately $9.21.
"AI is opening up the next big chapter for Veeva and life sciences," said CEO Peter Gassner. "Vault CRM had its best quarter ever and Veeva Falcon accelerated rapidly."
CFO Brian Van Wagener noted, "Second quarter results exceeded guidance on all metrics and our view for the full year improved across the board."
The company reported strong momentum in its Vault CRM platform, which now has more than 180 customers live, including five top 20 biopharmas. Veeva also highlighted progress with its Veeva Falcon agentic labor platform for clinical, regulatory, and safety functions, which has five early adopters and is on track for initial deployments this year.
Adjusted operating income for the quarter was $415.9 million, up 18% YoY from $352.6 million, while adjusted net income increased 16% to $387.4 million from $333.4 million in the year-ago period.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。